Takeda Pharmaceutical TAK
NYSE TAK
$18.31 -0.20 (-1.11%)
As of: Sep 30, 2026 · 2:45 PM EDT

Takeda Pharmaceutical (TAK) Convertible Debt (2018 - 2026)

Updated

Takeda Pharmaceutical (TAK) recorded Convertible Debt of $237.98 million in the quarter ended Jun 30, 2026, up 0.5% from $236.81 million a year earlier but down 0.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Convertible Debt (2018 - 2026) Analysis & Trends

As of Mar 31, 2026, Takeda Pharmaceutical reported Convertible Debt of $249.45 million, up 8.0% from the prior year.

  • Annual Convertible Debt has a five-year compound annual growth rate of -7.4% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Convertible Debt came in at $230.93 million in the year ended Mar 31, 2025 (+131.7%), $99.66 million in the year ended Mar 31, 2024 (-75.9%), $414.3 million in the year ended Mar 31, 2023 (-10.9%) and $464.94 million in the year ended Mar 31, 2022 (+27.2%).
  • Quarterly Convertible Debt has ranged from $81.57 million in the quarter ended Jun 30, 2024 to $485.32 million in the quarter ended Sep 30, 2022 over the past five years.
  • On a year-over-year basis, Convertible Debt has increased for seven consecutive quarters, with growth averaging 70.6% over the last eight quarters.
  • Peak year-over-year performance for Convertible Debt in the last five years was growth of 190.3% in the quarter ended Jun 30, 2025, against a decline of 81.2% in the quarter ended Jun 30, 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $239.44 million (quarter ended Mar 31, 2026), $221.32 million (quarter ended Dec 31, 2025) and $222.37 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Takeda Pharmaceutical 2.68 Bn -23.83 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 237.98 Mn
Mar 31, 2026 239.44 Mn
Dec 31, 2025 221.32 Mn
Sep 30, 2025 222.37 Mn
Jun 30, 2025 236.81 Mn
Mar 31, 2025 230.57 Mn
Dec 31, 2024 174.86 Mn
Sep 30, 2024 102.29 Mn
Jun 30, 2024 81.57 Mn
Mar 31, 2024 96.99 Mn
Dec 31, 2023 92.14 Mn
Sep 30, 2023 103.58 Mn
Jun 30, 2023 434.20 Mn
Mar 31, 2023 423.12 Mn
Dec 31, 2022 422.07 Mn
Sep 30, 2022 485.32 Mn
Jun 30, 2022 436.25 Mn
Mar 31, 2022 449.16 Mn
Jun 30, 2021 328.59 Mn
Mar 31, 2021 366.07 Mn
API Access

Takeda Pharmaceutical Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=TAK&period=max&api_key=YOUR_API_KEY